お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
874719

ゲノム編集の世界市場:技術(CRISPR/CAS9、TALEN/Mega TALs、ZFN)、送達方法(In-vivo、Ex-vivo)、用途、エンドユーザー、サービス、地域別

Genome Editing Market, By Technology (CRISPR/ Cas9, TALEN/Mega TALs, and ZFN), By Delivery method (Ex-vivo, In-vivo), By Application, By End Use, By Geography (NA, EU, APAC, and RoW) - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 156 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.68円
ゲノム編集の世界市場:技術(CRISPR/CAS9、TALEN/Mega TALs、ZFN)、送達方法(In-vivo、Ex-vivo)、用途、エンドユーザー、サービス、地域別
出版日: 2019年06月01日
発行: AnalystView Market Insights
ページ情報: 英文 156 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界のゲノム編集市場を調査し、市場の概要、技術・用途・送達方法・エンドユーザー・サービス・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、市場シェア、競合情勢、主要企業の分析など、包括的な情報を提供しています。

第1章 市場概要

第2章 エグゼクティブサマリー

  • 市場スニペット:セグメント別
  • 競争考察

第3章 市場動向

  • 成長要因
  • 阻害要因
  • 市場機会
  • 将来動向

第4章 産業分析

  • ファイブフォース分析
  • 市場戦略の分析
  • 成長見通し
  • 規制の枠組み

第5章 市場情勢

  • 市場シェアの分析
  • 主要イノベーター企業
  • 詳細データ:主要製造企業別

第6章 世界のゲノム編集市場:技術別

  • 市場概要
  • CRISPR/CAS9
  • ZFN
  • TALEN/Mega TALs
  • その他

第7章 世界のゲノム編集市場:用途別

  • 市場概要
  • 細胞株工学/遺伝子治療
  • 植物遺伝子工学
  • 動物遺伝子工学
  • その他

第8章 世界のゲノム編集市場:送達方法別

  • 市場概要
  • エクスビボ(Ex-vivo)
  • インビボ(In-vivo)

第9章 世界のゲノム編集市場:エンドユーザー別

  • 市場概要
  • バイオテクノロジー・製薬
  • 開発業務受託機関
  • 政府系研究機関
  • その他

第10章 世界のゲノム編集市場:サービス別

  • 市場概要
  • 自社
  • 契約

第11章 世界のゲノム編集市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第12章 主要ベンダーの分析

  • Merck KGaA
  • CRISPR THERAPEUTICS
  • Cibus
  • Intellia Therapeutics, Inc.
  • Recombinetics, Inc.
  • Sangamo
  • AstraZeneca
  • Caribou Biosciences, Inc.
  • Precision Biosciences
  • Editas Medicine Cellectis
  • Horizon Discovery Group
  • Lonza
図表

List of Tables

  • TABLE List of data Technology
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Genome Editing market: Technology snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE Genome Editing market: Application snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Genome Editing market, by Application 2014-2025 (USD Million)
  • TABLE Genome Editing market: Delivery Mode snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Delivery Mode
  • TABLE Global Genome Editing market, by Delivery Mode 2014-2025 (USD Million)
  • TABLE Genome Editing market: End Use snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by End Use
  • TABLE Global Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE Genome Editing market: Service snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by Service
  • TABLE Global Genome Editing market, by Service, 2014-2025 (USD Million)
  • TABLE Genome Editing market: regional snapshot (2018)
  • TABLE Segment Dashboard; Definition and Scope, by region
  • TABLE Global Genome Editing market, by region 2014-2025 (USD Million)
  • TABLE North America Genome Editing market, by country, 2014-2025 (USD Million)
  • TABLE North America Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE North America Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE North America Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE North America Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE North America Genome Editing market, by Service, 2014-2025 (USD Million)
  • TABLE U.S. Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE U.S. Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE U.S. Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE U.S. Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE U.S. Genome Editing market, by Services, 2014-2025 (USD Million)
  • TABLE Canada Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE Canada Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE Canada Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE Canada Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE Canada Genome Editing market, by Services, 2014-2025 (USD Million)
  • TABLE Europe Genome Editing market, by country, 2014-2025 (USD Million)
  • TABLE Europe Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE Europe Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE Europe Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE Europe Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE Europe Genome Editing market, by Services, 2014-2025 (USD Million)
  • TABLE Germany Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE Germany Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE Germany Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE Germany Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE Germany Genome Editing market, by Services, 2014-2025 (USD Million)
  • TABLE U.K. Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE U.K. Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE U.K. Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE U.K. Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE U.K. Genome Editing market, by Services, 2014-2025 (USD Million)
  • TABLE Rest of the Europe Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE Rest of the Europe Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE Rest of the Europe Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE Rest of the Europe Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE Rest of the Europe Genome Editing market, by Services, 2014-2025 (USD Million)
  • TABLE Asia Pacific Genome Editing market, by country, 2014-2025 (USD Million)
  • TABLE Asia Pacific Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE Asia Pacific Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE Asia Pacific Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE Asia Pacific Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE Asia Pacific Genome Editing market, by Services, 2014-2025 (USD Million)
  • TABLE Japan Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE Japan Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE Japan Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE Japan Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE Japan Genome Editing market, by Services, 2014-2025 (USD Million)
  • TABLE China Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE China Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE China Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE China Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE China Genome Editing market, by Services, 2014-2025 (USD Million)
  • TABLE Rest of Asia Pacific Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE Rest of Asia Pacific Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE Rest of Asia Pacific Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE Rest of Asia Pacific Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE Rest of Asia Pacific Genome Editing market, by Services, 2014-2025 (USD Million)
  • TABLE Rest of the World Genome Editing market, by country, 2014-2025 (USD Million)
  • TABLE Rest of the World Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE Rest of the World Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE Rest of the World Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE Rest of the World Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE Rest of the World Genome Editing market, by Services, 2014-2025 (USD Million)
  • TABLE Latin America Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE Latin America Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE Latin America Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE Latin America Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE Latin America Genome Editing market, by Services, 2014-2025 (USD Million)
  • TABLE Middle East and Africa Genome Editing market, by Technology, 2014-2025 (USD Million)
  • TABLE Middle East and Africa Genome Editing market, by Application, 2014-2025 (USD Million)
  • TABLE Middle East and Africa Genome Editing market, by Delivery Mode, 2014-2025 (USD Million)
  • TABLE Middle East and Africa Genome Editing market, by End Use, 2014-2025 (USD Million)
  • TABLE Middle East and Africa Genome Editing market, by Services, 2014-2025 (USD Million)

List of Figures

  • FIGURE Genome Editing market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Technology segment market share analysis, 2017 & 2025
  • FIGURE Technology segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE CRISPR/ Cas9 market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE ZFN market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE TALEN/Mega TALs market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Application segment market share analysis, 2017 & 2025
  • FIGURE Application segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Cell Line Engineering/Gene Therapy market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Plant Genetic Engineering market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Animal Genetic Engineering market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Delivery Mode segment market share analysis, 2017 & 2025
  • FIGURE Delivery Mode segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Ex-vivo market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE In-vivo market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE End Use segment market share analysis, 2017 & 2025
  • FIGURE End Use segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Biotechnology & Pharmaceutical Industries market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Contract Research Organizations market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Government Research Institutes market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Others market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Services segment market share analysis, 2017 & 2025
  • FIGURE Services segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE In-house market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Contract market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Regional segment market share analysis, 2017 & 2025
  • FIGURE Regional segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE North America Genome Editing market share and leading players, 2018
  • FIGURE Europe Genome Editing market share and leading players, 2018
  • FIGURE Asia Pacific Genome Editing market share and leading players, 2018
  • FIGURE Latin America Genome Editing market share and leading players, 2018
  • FIGURE Middle East and Africa Genome Editing market share and leading players, 2018
  • FIGURE North America market share analysis by country, 2018
  • FIGURE U.S. market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Canada market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Europe market share analysis by country, 2018
  • FIGURE U.K. market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Germany market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Rest of the Europe market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Asia Pacific market share analysis by country, 2018
  • FIGURE India market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE China market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Rest of Asia Pacific market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Rest of the World market share analysis by country, 2018
  • FIGURE Latin America market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Middle East and Africa market size, forecast and trend analysis, 2014 to 2025 (USD Million)
目次

Title:
Genome Editing Market, By Technology (CRISPR/ Cas9, TALEN/Mega TALs, and ZFN), By Delivery method (Ex-vivo, In-vivo), By Application, By End Use, By Geography (NA, EU, APAC, and RoW) - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

REPORT HIGHLIGHT

The Genome Editing market was valued at USD 3.98 billion by 2017, growing with 10.68% CAGR during the forecast period, 2018-2025.

MARKET DYNAMICS

The study or practice of genome editing is one where genetic material is modified or manipulated within living organisms. This is done with the purpose of improving the quality of the organism. It is used in cases of crops and micro-organisms to improve the overall efficacy of the outcome or product that is expected. High-end technology is used to carry out highly sophisticated procedures such as this. Consistent technological advancement in this field will result in an escalation in the industry growth for genome editing. There is an increase in the funding by the government organizations for such R&D activities, thus acting as a catalyst to this growth. Advancement in technology such as the development of the CRISPR- Cas9 is a huge milestone in genome editing technology. The most significant market restraints include toxicity data associated with the activity of nucleases, besides this concerns addressed by animal rights activist and environmentalist over the ethics of genome editing is a rising concern.

TECHNOLOGY TAKEAWAY

Technologically the market is divided into CRISPR/ Cas9, TALEN/Mega TALs, ZFN, Others. CRISPR- Cas9 is one of the biggest and most revolutionary developments in the gene editing segment. It was taken in from a naturally occurring bacteria. The gene captures portion of DNA from an invading virus. These are also known as CRISPR arrays that help the gene remember the virus or sequence. This technology holds up to 45% of the market share in terms of revenue generation. Increase in R&D activities in vaccinations and drugs will boost this technology. Some of the others include TALEN/ Mega TAL's and ZFN. The Zinc finger nucleases will also experience significant growth in this category.

APPLICATION TAKEAWAY

Application wise this market is categorized as following, Cell Line Engineering/Gene Therapy, Animal Genetic Engineering, Plant Genetic Engineering, Other. Animal genetic engineering holds the most significant market share. A rise in dairy technology is a contributor to this industry. Following which the plant genetic engineering may be set to have a considerable increase in this segment.

DELIVERY METHODS TAKEAWAY

Two primary methods are used in order to carry out gene editing. These include ex vivo method and in vivo. Ex Vivo is the largest in terms of revenue generation. Ex vivo allows having better control over dosages being delivered to the cells.

END-USE TAKEAWAY

Based on end use the categorization is as follows Biotechnology & Pharmaceutical Industries, Academic & Government Research Institutes, Contract Research Organizations, Others. Pharmaceutical and biotechnological companies are spending a significant amount of time on R&D of various diseases and drug delivery and development. Research institutes own about one-third of the market chunk in terms of revenue.

REGION TAKEAWAY

U.S market will witness significant growth. The biggest contributing factor for this is the favourable regulatory scenario for this industry. India is also a booming market for an R&D standpoint. Growth in the number of initiatives that the government is taking to support this field makes it even more favourable in a developing country. India being an agriculturally driven country, there is tremendous scope and demand for crops that are genetically more productive and effective. Ongoing studies will help propel this industry in the right direction.

KEY VENDOR TAKEAWAY

Companies such Merck KGaA, CRISPR THERAPEUTICS, Cibus, Intellia Therapeutics, Inc., Recombinetics, Inc., Sangamo, AstraZeneca, Caribou Biosciences, Inc., Precision Biosciences, Editas Medicine Cellectis, Horizon Discovery Group, and Lonza are some of the market leaders with respect to the genetic editing.

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year - 2014 & 2016
  • Base Year - 2017
  • Estimated Year - 2018
  • Projected Year - 2025

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government and Regional Agencies and Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY TECHNOLOGY

  • CRISPR/ Cas9
  • ZFN
  • TALEN/Mega TALs
  • Others

MARKET, BY APPLICATION

  • Cell Line Engineering/Gene Therapy
  • Plant Genetic Engineering
  • Animal Genetic Engineering
  • Others

MARKET, BY DELIVERY MODE

  • Ex-vivo
  • In-vivo

MARKET, BY END USE

  • Biotechnology & Pharmaceutical Industries
  • Contract Research Organizations
  • Government Research Institutes
  • Others

MARKET, BY SERVICE

  • In-house
  • Contract

MARKET, BY REGION

  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of APAC
  • Rest of the World
    • Middle East and Africa
    • Latin America

TABLE OF CONTENT

1. GENOME EDITING MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Market Snippet
    • 2.1.1. Market Snippet by Technology
    • 2.1.2. Market Snippet by Application
    • 2.1.3. Market Snippet by Delivery Mode
    • 2.1.4. Market Snippet by End Use
    • 2.1.5. Market Snippet by Service
    • 2.1.6. Market Snippet by Region
  • 2.2. Competitive Insights

3. GENOME EDITING KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. GENOME EDITING INDUSTRY STUDY

  • 4.1. Porter's Five Forces Analysis
  • 4.2. Marketing Strategy Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. GENOME EDITING MARKET LANDSCAPE

  • 5.1. Market Share Analysis
  • 5.2. Key Innovators
  • 5.3. Breakdown Data, by Key manufacturer
    • 5.3.1. Established Player Analysis
    • 5.3.2. Emerging Player Analysis

6. GENOME EDITING MARKET - BY TECHNOLOGY

  • 6.1. Overview
    • 6.1.1. Segment Share Analysis, By Technology, 2017 & 2025 (%)
  • 6.2. CRISPR/ Cas9
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.3. ZFN
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.4. TALEN/Mega TALs
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.5. Others
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

7. GENOME EDITING MARKET - BY APPLICATION

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Application, 2017 & 2025 (%)
  • 7.2. Cell Line Engineering/Gene Therapy
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.3. Plant Genetic Engineering
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.4. Animal Genetic Engineering
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.5. Others
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

8. GENOME EDITING MARKET - BY DELIVERY MODE

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Delivery Mode, 2017 & 2025 (%)
  • 8.2. Ex-vivo
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 8.3. In-vivo
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

9. GENOME EDITING MARKET - BY END USE

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2017 & 2025 (%)
  • 9.2. Biotechnology & Pharmaceutical Industries
    • 9.2.1. Overview
    • 9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 9.3. Contract Research Organizations
    • 9.3.1. Overview
    • 9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 9.4. Government Research Institutes
    • 9.4.1. Overview
    • 9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 9.5. Others
    • 9.5.1. Overview
    • 9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

10. GENOME EDITING MARKET - BY SERVICE

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Service, 2017 & 2025 (%)
  • 10.2. In-house
    • 10.2.1. Overview
    • 10.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 10.3. Contract
    • 10.3.1. Overview
    • 10.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

11. GENOME EDITING MARKET- BY GEOGRAPHY

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Region, 2017 & 2025 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Technology, 2014 - 2025 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2014 - 2025 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Delivery Mode, 2014 - 2025 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End Use, 2014 - 2025 (US$ Million)
    • 11.2.8. North America Market Size and Forecast, By Service, 2014 - 2025 (US$ Million)
    • 11.2.9. U.S.
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.2.10. Canada
    • 11.2.10.1. Overview
    • 11.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Technology, 2014 - 2025 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2014 - 2025 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Delivery Mode, 2014 - 2025 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End Use, 2014 - 2025 (US$ Million)
    • 11.3.8. Europe Market Size and Forecast, By Service, 2014 - 2025 (US$ Million)
    • 11.3.9. France
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.3.10. Germany
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.3.11. Rest of Europe
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Technology, 2014 - 2025 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2014 - 2025 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Delivery Mode, 2014 - 2025 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End Use, 2014 - 2025 (US$ Million)
    • 11.4.8. Asia Pacific Market Size and Forecast, By Service, 2014 - 2025 (US$ Million)
    • 11.4.9. China
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.4.10. India
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.4.11. Rest of APAC
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 11.5. Rest of the World
    • 11.5.1. Overview
    • 11.5.2. Key Manufacturers in Rest of the World
    • 11.5.3. Rest of the World Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 11.5.4. Rest of the World Market Size and Forecast, By Technology, 2014 - 2025 (US$ Million)
    • 11.5.5. Rest of the World Market Size and Forecast, By Application, 2014 - 2025 (US$ Million)
    • 11.5.6. Rest of the World Market Size and Forecast, By Delivery Mode, 2014 - 2025 (US$ Million)
    • 11.5.7. Rest of the World Market Size and Forecast, By End Use, 2014 - 2025 (US$ Million)
    • 11.5.8. Rest of the World Market Size and Forecast, By Service, 2014 - 2025 (US$ Million)
    • 11.5.9. Latin America
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 11.5.10. Middle East and Africa
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

12. KEY VENDOR ANALYSIS

  • 12.1. Merck KGaA
    • 12.1.1. Company Snapshot
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Strategic Initiatives
  • 12.2. CRISPR THERAPEUTICS
    • 12.2.1. Company Snapshot
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Strategic Initiatives
  • 12.3. Cibus
    • 12.3.1. Company Snapshot
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Strategic Initiatives
  • 12.4. Intellia Therapeutics, Inc.
    • 12.4.1. Company Snapshot
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Strategic Initiatives
  • 12.5. Recombinetics, Inc.
    • 12.5.1. Company Snapshot
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Strategic Initiatives
  • 12.6. Sangamo
    • 12.6.1. Company Snapshot
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Strategic Initiatives
  • 12.7. AstraZeneca
    • 12.7.1. Company Snapshot
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Strategic Initiatives
  • 12.8. Caribou Biosciences, Inc.
    • 12.8.1. Company Snapshot
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Strategic Initiatives
  • 12.9. Precision Biosciences
    • 12.9.1. Company Snapshot
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Strategic Initiatives
  • 12.10. Editas Medicine Cellectis
    • 12.10.1. Company Snapshot
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Strategic Initiatives
  • 12.11. Horizon Discovery Group
    • 12.11.1. Company Snapshot
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Strategic Initiatives
  • 12.12. Lonza
    • 12.12.1. Company Snapshot
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Strategic Initiatives

13. 360 DEGREE ANALYSTVIEW

14. APPENDIX

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.